A serotoninergic mechanism for the control of insulin secretion.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000037:antagonists & inhibitors; D003533:Cyproheptadine / Q000494:pharmacology; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism; D008784:Methysergide / Q000494:pharmacology; D010179:Pancreas / Q000378:metabolism; D010643:Phenoxybenzamine / Q000494:pharmacology; D010919:Placebos; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D011863:Radioimmunoassay; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical; D013311:Streptozocin / Q000494:pharmacology
D002395:Catecholamines; D007328:Insulin; D010919:Placebos; D012702:Serotonin Antagonists; D010643:Phenoxybenzamine; D003533:Cyproheptadine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D013311:Streptozocin; D011433:Propranolol; D006916:5-Hydroxytryptophan; D005947:Glucose; D008784:Methysergide